Neuropathy, or peripheral neuropathy, denotes the impairment or malfunction of peripheral nerves, which form the extensive network outside the brain and spinal cord. These nerves serve as conduits for transmitting signals between the central nervous system and the body, regulating sensations, movements, and organ function. A multitude of factors can precipitate neuropathy, spanning from diabetes and autoimmune conditions to infections like Lyme disease or HIV, traumatic injuries, and exposure to toxins or certain medications. The manifestations of neuropathy vary widely based on the underlying cause and the specific nerves affected, often presenting as numbness, tingling, weakness, or pain in the afflicted regions. In severe instances, neuropathy can culminate in muscle wasting, diminished coordination, and impaired organ functionality. Managing neuropathy pivots on addressing the root cause, where feasible, and alleviating symptoms to bolster quality of life. Treatment modalities may encompass pharmacotherapy to assuage pain and quell inflammation, lifestyle adjustments such as regular exercise and a nutritious diet to manage conditions like diabetes, and physical therapy aimed at bolstering strength, balance, and mobility.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States